Anthropometric measurements as a key diagnostic tool for familial partial lipodystrophy in women.

IF 3.4 3区 医学 Q2 ENDOCRINOLOGY & METABOLISM
Victor Rezende Veras, Grayce Ellen da Cruz Paiva Lima, Ivana da Ponte Melo, Virginia Oliveira Fernandes, Fabia Karine de Moura Lopes, Camila Lopes do Amaral, Maria Helane Gurgel Castelo, Larissa Luna Queiroz, Jessica Silveira Araújo, Cynthia Melissa Valerio, Renan Magalhães Montenegro Junior
{"title":"Anthropometric measurements as a key diagnostic tool for familial partial lipodystrophy in women.","authors":"Victor Rezende Veras, Grayce Ellen da Cruz Paiva Lima, Ivana da Ponte Melo, Virginia Oliveira Fernandes, Fabia Karine de Moura Lopes, Camila Lopes do Amaral, Maria Helane Gurgel Castelo, Larissa Luna Queiroz, Jessica Silveira Araújo, Cynthia Melissa Valerio, Renan Magalhães Montenegro Junior","doi":"10.1186/s13098-024-01413-w","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Familial Partial Lipodystrophy (FPLD) is a disease with wide clinical and genetic variation, with seven different subtypes described. Until genetic testing becomes feasible in clinical practice, non-invasive tools are used to evaluate body composition in lipodystrophic patients. This study aimed to analyze the different anthropometric parameters used for screening and diagnosis of FPLD, such as thigh skinfold thickness (TS), Köb index (Köbi), leg fat percentage (LFP), fat mass ratio (FMR) and leg-to-total fat mass ratio in grams (LTR), by dual-energy X-ray absorptiometry, focusing on determining cutoff points for TS and LFP within a Brazilian population.</p><p><strong>Methods: </strong>Thirty-seven patients with FPLD and seventy-four healthy controls matched for body mass index, sex and age were studied. Data were collected through medical record review after signing informed consent. All participants had body fat distribution evaluated by skinfolds and DXA measures. Fasting blood samples were collected to evaluate glycemic and lipid profiles. Genetic studies were carried out on all patients. Two groups were categorized based on genetic testing and/or anthropometric characteristics: FPLD+ (positive genetic test) and FPLD1 (negative genetic testing, but positive clinical/anthropometric criteria for FPLD).</p><p><strong>Results: </strong>Eighteen (48.6%) patients were classified as FPLD+, and 19 (51.4%) as FPLD1. Unlike what is described in the literature, the LMNA variant in codon 582 was the most common. Among the main diagnostic parameters of FPLD, a statistical difference was observed between the groups for, Köbi, TS, LFP, FMR, and LTR. A cutoff point of 20 mm for TS in FPLD women was found, which is lower than the value classically described in the literature for the diagnosis of FPLD. Additionally, an LFP < 29.6% appears to be a useful tool to aid in the diagnosis of these women.</p><p><strong>Conclusion: </strong>Combining anthropometric measurements to assess body fat distribution can lead to a more accurate diagnosis of FPLD. This study suggests new cutoff points for thigh skinfold and leg fat percentage in women with suspected FPLD in Brazil. Further studies are needed to confirm these findings.</p>","PeriodicalId":11106,"journal":{"name":"Diabetology & Metabolic Syndrome","volume":"16 1","pages":"216"},"PeriodicalIF":3.4000,"publicationDate":"2024-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11373399/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Diabetology & Metabolic Syndrome","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s13098-024-01413-w","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Familial Partial Lipodystrophy (FPLD) is a disease with wide clinical and genetic variation, with seven different subtypes described. Until genetic testing becomes feasible in clinical practice, non-invasive tools are used to evaluate body composition in lipodystrophic patients. This study aimed to analyze the different anthropometric parameters used for screening and diagnosis of FPLD, such as thigh skinfold thickness (TS), Köb index (Köbi), leg fat percentage (LFP), fat mass ratio (FMR) and leg-to-total fat mass ratio in grams (LTR), by dual-energy X-ray absorptiometry, focusing on determining cutoff points for TS and LFP within a Brazilian population.

Methods: Thirty-seven patients with FPLD and seventy-four healthy controls matched for body mass index, sex and age were studied. Data were collected through medical record review after signing informed consent. All participants had body fat distribution evaluated by skinfolds and DXA measures. Fasting blood samples were collected to evaluate glycemic and lipid profiles. Genetic studies were carried out on all patients. Two groups were categorized based on genetic testing and/or anthropometric characteristics: FPLD+ (positive genetic test) and FPLD1 (negative genetic testing, but positive clinical/anthropometric criteria for FPLD).

Results: Eighteen (48.6%) patients were classified as FPLD+, and 19 (51.4%) as FPLD1. Unlike what is described in the literature, the LMNA variant in codon 582 was the most common. Among the main diagnostic parameters of FPLD, a statistical difference was observed between the groups for, Köbi, TS, LFP, FMR, and LTR. A cutoff point of 20 mm for TS in FPLD women was found, which is lower than the value classically described in the literature for the diagnosis of FPLD. Additionally, an LFP < 29.6% appears to be a useful tool to aid in the diagnosis of these women.

Conclusion: Combining anthropometric measurements to assess body fat distribution can lead to a more accurate diagnosis of FPLD. This study suggests new cutoff points for thigh skinfold and leg fat percentage in women with suspected FPLD in Brazil. Further studies are needed to confirm these findings.

人体测量是诊断女性家族性部分脂肪营养不良症的重要工具。
背景:家族性部分性脂肪营养不良症(FPLD)是一种临床和遗传差异很大的疾病,目前已发现七种不同的亚型。在基因检测在临床实践中变得可行之前,人们使用非侵入性工具来评估脂肪营养不良患者的身体成分。本研究旨在通过双能 X 射线吸收测量法,分析用于筛查和诊断 FPLD 的不同人体测量参数,如大腿皮褶厚度(TS)、Köb 指数(Köbi)、腿部脂肪百分比(LFP)、脂肪质量比(FMR)和腿部与总脂肪质量比克数(LTR),重点是确定巴西人群中 TS 和 LFP 的临界点:研究对象包括 37 名 FPLD 患者和 74 名在体重指数、性别和年龄方面匹配的健康对照者。在签署知情同意书后,通过查阅病历收集数据。所有参与者的体脂分布均通过皮褶和 DXA 测量进行了评估。收集空腹血样以评估血糖和血脂状况。对所有患者进行了基因研究。根据基因检测结果和/或人体测量特征分为两组:FPLD+(基因检测呈阳性)和 FPLD1(基因检测呈阴性,但 FPLD 的临床/人体测量标准呈阳性):结果:18 名患者(48.6%)被归类为 FPLD+,19 名患者(51.4%)被归类为 FPLD1。与文献描述不同的是,密码子 582 中的 LMNA 变异最为常见。在 FPLD 的主要诊断参数中,Köbi、TS、LFP、FMR 和 LTR 在组间存在统计学差异。研究发现,FPLD 女性 TS 的临界点为 20 毫米,低于文献中用于诊断 FPLD 的标准值。此外,LFP 结论:结合人体测量来评估体脂分布可使 FPLD 诊断更加准确。本研究提出了巴西女性疑似 FPLD 患者大腿皮褶和腿部脂肪百分比的新临界点。还需要进一步的研究来证实这些发现。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Diabetology & Metabolic Syndrome
Diabetology & Metabolic Syndrome ENDOCRINOLOGY & METABOLISM-
CiteScore
6.20
自引率
0.00%
发文量
170
审稿时长
7.5 months
期刊介绍: Diabetology & Metabolic Syndrome publishes articles on all aspects of the pathophysiology of diabetes and metabolic syndrome. By publishing original material exploring any area of laboratory, animal or clinical research into diabetes and metabolic syndrome, the journal offers a high-visibility forum for new insights and discussions into the issues of importance to the relevant community.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信